Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with verticals in industries, including artificial intelligence, machine learning, and healthcare. Its products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and dark Web, making predictive analytics. This platform provides insights into market trends and direct customer feedback. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amount of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform.


TSXV:DM - Post by User

Comment by Kensin1954on Dec 09, 2021 2:50pm
135 Views
Post# 34215694

RE:covid test revenue

RE:covid test revenueTankUmo you are 100% correct.

World leaders right now are looking to budget high level testing paid for by their governments so that they can get cash flowing again. 

I'm not kidding when I said a $50 mill Contract for test kits owuld not be out of the realm of reasonableness. 

$100 mil for 2022 at 40% margins at DM given guaranteed supply and high accuracy seems about right to me.

Then there will be the SCRN component that will start to take off. BTC will also firm up end of this month so GBLC will pop.

Anything AI will be all paid for and pure profit. This is why M.G. appears so confident. 

I disagree with Mason on everything except his post on a $1.00 CDN as Mason's target. My time line is third quarter 2022. 

Watch for continued N.R. coming to a platform on your systems soon.

JMHO
<< Previous
Bullboard Posts
Next >>